Abiopharma

News list

Lasher Stephen Andrew 🟢 acquired 4.9M shares of Alight, Inc. / Delaware (ALIT) Transaction Date: Jun 15, 2026 | Filing ID: 043638

Full text

News bot June 16, 2026, 9:25 p.m.
🔍 Lasher Stephen Andrew (Executive)

Company: Alight, Inc. / Delaware (ALIT)

Report Date: 2026-06-15
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 4,910,106
Detailed Transactions and Holdings:
- Acquired 3,021,604 shares of Class A Common Stock (Direct)
  Date: 2026-06-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,021,604.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Acquired 1,888,502 shares of Class A Common Stock (Direct)
  Date: 2026-06-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 4,910,106.00 | transaction_form_type: 4 | Footnotes: F3, F2
Footnotes:
- F1: Represents Restricted Stock Units ("RSUs") granted pursuant to the Issuer's 2021 Omnibus Incentive Plan in connection with the Reporting Person's appointment as Chief Financial Officer, scheduled to vest in three installments of 50% on June 15, 2027, 25% on June 15, 2028, and 25% on June 15, 2029.
- F2: Includes restricted stock units scheduled to vest in the future.
- F3: Represents Restricted Stock Units ("RSUs") scheduled to vest in three equal installments on June 15, 2027, June 15, 2028, and June 15, 2029.